MDR TB
Showing 1 - 25 of 1,125
MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)
Recruiting
- MDR-TB
- Immunotherapy
- Vγ2Vδ2 T lymphocyte-based immunotherapy
- Treatment regimens for MDR-TB
-
Shanghai, China
- +1 more
Aug 8, 2022
MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))
Recruiting
- MDR-TB
- PRS Regimen V
- MDR-TB Treatment Regimen(WHO)
-
Shanghai, ChinaShanghai Pulmonary Hospital
Aug 4, 2022
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Pre-XDR-TB Trial in Seoul (BPaL regimen)
Not yet recruiting
- Pre-XDR-TB
- BPaL regimen
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 19, 2022
Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®
Terminated
- Tuberculosis, Multidrug Resistant
- RUTI® Therapeutic vaccine
- Matching RUTI® Placebo
-
Chernivtsi, Ukraine
- +2 more
Jun 30, 2022
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)
Completed
- Multi-drug Resistant Tuberculosis
- 18-month regimen containing 6 anti-TB drugs
-
Beijing, China
- +19 more
Oct 10, 2022
Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic
Not yet recruiting
- Tuberculosis
- 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
- +5 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Oct 11, 2021
MDR-TB, HIV Trial in South Africa (NCM-Plus)
Active, not recruiting
- MDR-TB
- HIV
- NCM-Plus
-
Westville, Durban, South Africa
- +14 more
Nov 16, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,
Active, not recruiting
- Tuberculosis, Pulmonary
- +5 more
- Pretomanid
- +3 more
-
Tbilisi, Georgia
- +10 more
Jan 26, 2022
Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for
Not yet recruiting
- Tuberculosis
- Rifampicin Resistant Tuberculosis
- Pretomanid
- Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
-
Rio De Janeiro, Brazil
- +6 more
Oct 18, 2022
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Recruiting
- Drug Resistant Tuberculosis
- +3 more
- Xpert® MTB/XDR
-
Gulele, Addis Ababa, Ethiopia
- +3 more
Jun 13, 2022
Expand New Drugs for TB [endTB]
Completed
- Tuberculosis, Multidrug-Resistant
- This is a non-intervention observational study
-
Abovyan, Armenia
- +15 more
Jun 9, 2022
Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)
Active, not recruiting
- Tuberculosis
- +3 more
- therapeutical surgery for TB
-
Tbilisi, GeorgiaNational Center for Tuberculosis and Lung Diseases
Sep 9, 2022
Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +7 more
-
Tbilisi, Georgia
- +11 more
Feb 14, 2022
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South
Recruiting
- Multi-drug Resistant Tuberculosis
- +2 more
- Bedaquiline
- +5 more
-
Minsk, Belarus
- +6 more
May 12, 2021
MDR-TB Trial in Kibong'oto (Therapeutic drug monitoring (TDM))
Completed
- MDR-TB
- Therapeutic drug monitoring (TDM)
-
Kibong'oto, TanzaniaKibong'oto infectious diseases hospital
Oct 28, 2020
Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG
Recruiting
- Tuberculosis, Multidrug-Resistant
- +5 more
- Bedaquiline 100 MG
- +4 more
-
Pune, India
- +9 more
Mar 2, 2022
Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))
Recruiting
- Tuberculosis, MDR
- Delamanid (DLM)
- +2 more
-
Gaborone, South-East District, Botswana
- +26 more
Sep 22, 2022
Pre-Extensively Drug-Resistant Pulmonary TB, Treatment Intolerant Multidrug-Resistant Pulmonary TB, Non-responsive
Recruiting
- Pre-Extensively Drug-Resistant Pulmonary TB
- +2 more
- Linezolid
- +2 more
-
Agra, Uttarpradesh, IndiaS N Medical College
Nov 8, 2021
Tuberculosis Research of INA-RESPOND On Drug Resistance
Completed
- Lung Tuberculosis
- MDR TB
- No Intervention
-
Denpasar, Bali, Indonesia
- +6 more
Nov 17, 2021
Multi-drug Resistant Tuberculosis Trial in Lambarene (Km+ Mfx+ Pto + H + Cfz +E+Z)
Recruiting
- Multi-drug Resistant Tuberculosis
- Km+ Mfx+ Pto + H + Cfz +E+Z
-
Lambarene, Please Select, GabonCentre de Recherches Médicales de Lambaréné
Jul 26, 2021